EveryDose, a digital health company founded in 2016, aims to improve medication adherence through best-in-class technology. The slogan "Helping payers and health systems improve medication adherence with best-in-class technology" reflects the company's mission. The AI-powered platform assists patients in staying on track with their medications while driving lower costs, better outcomes, and higher quality measures for health plans and health systems. EveryDose operates in the Health Care and Insurtech industries with its headquarters in the United States. The company recently secured a significant milestone with a $3.75M Seed Round investment on 20 October 2020. This funding signifies a validation of EveryDose's innovative approach to medication adherence and marks a key step in the company's growth trajectory. While the specific investors for this round are not disclosed, this injection of capital will undoubtedly bolster EveryDose's efforts in revolutionizing the medication experience through intelligent patient engagement and actionable insights for clinical stakeholders.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Seed Round | $3.75M | - | 20 Oct 2020 | |
Seed Round | $1.55M | - | 08 Aug 2017 |
No recent news or press coverage available for EveryDose.